AstraZeneca (AZN) to Join Nasdaq-100 Index
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil steadies on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Five things to watch in markets in the week ahead
- Citi sees room for further equities upside in 2027 on resilient earnings growth
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- Schneider Electric to buy US software firm PTC in $22.6 billion deal
- BofA Securities Upgrades DraftKings Inc. (DKNG) to Buy
AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022
February 10, 2022 5:00 PM ESTNEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that AstraZeneca PLC ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC ADR will replace Xilinx, Inc. (Nasdaq: XLNX) in the NASDAQ-100 Index® and... More



